A study published in the New England Journal Of Medicine (NEJM) by Dutch researchers revealed improved survival outcomes in ovarian cancer patients. The patients received a heated chemotherapy organ bath circulated throughout the abdomen after surgery. The fluid was heated to degrees 40 degrees Celsius and was circulated in stage II epithelial ovarian, fallopian tube or peritoneal cancer. After the tumor removal, clinicians warmed cisplatin and circulated through the open abdominal cavity for 90 minutes.
The fluid was drained later. Subsequently, all the women received three cycles of the drugs carboplatin and paclitaxel. So far, the clinicians have observed the likelihood of survival for three years after surgery is 48% while with chemotherapy bath it was increased to 62%. However, the extra time needed in the operating room, additional cost of this procedure, and the presence of a…
